The expertise of Orano in advanced nuclear technologies has enabled the
development of a method for the stable extraction of high-purity
lead-212. Already used in the research against cancer, this radioactive
isotope coming from the decay chain of thorium-232,
was all too rare. This shortage was hampering research on alpha therapy.
At present, two lead-212 production units in France and the United
States offer an invaluable supply for the medical community and the